Prospective study of tardive dyskinesia in the elderly: Rates and risk factors

American Journal of Psychiatry

Volumn 155, Issue 11, 1998, Pages 1521-1528

  Woerner, Margaret G ^a   Alvir, Jose Ma J ^b   Saltz, Bruce L ^b   Lieberman, Jeffrey A ^b   Kane, John M ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; TARDIVE DYSKINESIA;

EID: 0031790237     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.11.1521     Document Type: Article

References (33)

1. Kane JM, Smith J: Tardive dyskinesia: prevalence and risk factors - 1959-1979. Arch Gen Psychiatry 1982; 39:473-481
2. Smith JM, Baldessarini RJ: Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 1980; 37:1368-1371
3. Khot V, Wyatt RJ: Not all that moves is tardive dyskinesia. Am J Psychiatry 1991; 148:661-666
4. Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC, APA, 1992
5. Harrington C, Tompkins C, Curtis M, Grant L: Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 1992; 32:822-833
6. Yassa R, Nastase C, Dupont D, Thibeau M: Tardive dyskinesia in elderly psychiatric patients: a 5-year study. Am J Psychiatry 1992; 149:1206-1211
7. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA: Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 1995; 52:756-765
8. Saltz BL, Woerner MG, Kane JM, Lieberman JA, Alvir JMJ, Bergmann KJ, Blank K, Koblenzer J, Kahaner K: Prospective study of tardive dyskinesia incidence in the elderly. JAMA 1991; 266:2402-2406
9. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976
10. Schooler NR, Kane JM: Research diagnoses for tardive dyskinesia (letter). Arch Gen Psychiatry 1982; 39:486-487
11. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
12. Woerner MG, Mannuzza S, Kane JM: Anchoring the BPRS: an aid to improved reliability. Psychopharmacol Bull 1988; 24: 112-117
13. Simpson GM, Lee JH, Zoubok B, Gardos G: A rating scale for tardive dyskinesia. Psychopharmacology (Berl) 1979; 64: 171-179
14. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19
15. SAS/STAT Software: Changes and Enhancements, Release 6.10. Cary, NC, SAS Institute, 1994
16. SAS/STAT User's Guide, version 6, 4th ed, vol 2. Cary, NC, SAS Institute, 1989
17. Woerner MG, Alvir JMJ, Kane JM, Saltz BL, Lieberman JA: Neuroleptic treatment of elderly patients. Psychopharmacol Bull 1995; 31:333-337
18. Gardos G, Casey D: Tardive Dyskinesia and Affective Disorders. Washington, DC, American Psychiatric Press, 1983
19. Kane JM, Woerner M, Lieberman J: Tardive dyskinesia: prevalence, incidence and risk factors. J Clin Psychopharmacol 1988; 8(suppl):52S-56S
20. Morgenstern H, Glazer W: Identifying risk factors of tardive dyskinesia among long-term outpatients maintained with neuroleptic medications: results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 1993; 50:723-733
21. Cole JO, Gardos G, Boling LA, Marby D, Haskell D, Moore P: Early dyskinesia - vulnerability. Psychopharmacology (Berl) 1992; 107:503-510
22. Rey JM, Hunt GE, Johnson GF: Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale. Aust NZ J Psychiatry 1981; 15:33-37
23. Kok LP, Christopher YS: Tardive dyskinesia in schizophrenic outpatients. Ann Acad Med Singapore 1985; 14:87-90
24. Schwartz M, Silver H, Tal I, Sharf B: Tardive dyskinesia in northern Israel: preliminary study. Eur Neurol 1993; 33:262-266
25. O'Hara P, Brugha TS, Lesage A, Wing J: New findings on tardive dyskinesia in a community sample. Psychol Med 1993; 23:453-465
26. Krueger RB, Sackheim HA: Electroconvulsive therapy and schizophrenia, in Schizophrenia. Edited by Hirsch SR, Weinberger DR. Oxford, England, Blackwell Science, 1995, pp 305-545
27. Brandon S, McClelland HA, Protheroe C: A study of facial dyskinesia in a mental hospital population. Br J Psychiatry 1971; 118:171-184
28. Delwaide PJ, Desseilles M: Spontaneous buccolingual-facial dyskinesia in the elderly. Acta Neurol Scand 1974; 56:256-262
29. Woerner MG, Saltz BL, Kane JM, Lieberman JA, Alvir JMJ: Diabetes and development of tardive dyskinesia. Am J Psychiatry 1993; 150:966-968
30. Ganzini L, Heintz RT, Hoffman WF, Casey DE: The prevalence of tardive dyskinesia in neuroleptic treated diabetics. Arch Gen Psychiatry 1991; 48:259-263
31. Mukherjee S, Reddy R, Schnur DB: Diabetes mellitus and tardive dyskinesia. Biol Psychiatry 1991; 1:624-627
32. Kane JM, Woerner MG, Pollack S, Safferman AZ, Lieberman JA: Does clozapine cause tardive dyskinesia? J Clin Psychiatry 1993; 54:327-330
33. Tollefson GD, Beasley CM Jr, Tamura RN, Tran PV, Potvin JH: Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997; 154:1248-1254